A Review of Mutations Causing Deficiencies of Antithrombin, Protein C and Protein S

• References

• 1 Egeberg O. Inherited antithrombin III deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-530
• 2 Lane DA, Olds RR, Thein SL. Antithrombin and its deficiency states. Blood Coag Fibrinol 1992; 3: 315-341
• 3 Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost 1993; 70 (01) 29-35
• 4 Esmon CT. Protein S and protein C. Biochemistry, physiology, and clinical manifestation of deficiencies. Trends Cardiovasc Med 1992; 2: 214-219
• 5 Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-2877
• 6 Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 1994; 91: 2728-2732
• 7 Dahlback B, Carlsson M, Svens sonP. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
• 8 Bertina RM, Koeleman B PC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 9 Molho-Sabatier P, Aiach M, Gaillard I, Fiessinger JN, Fischer AM, Chadeuf G, Clauser E. Molecular characterization of seven AT III variants using PCR. Identification of a new mutation: Ala 384-Pro. J Gin Invest 1989; 84: 1236-1242
• 10 Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Cooper DN, Blajchman M, Perry D, Emmerich J, Aiach M. Antithrombin III mutation database: First update. For the thrombin and its inhibitors subcommittee of the scientific and standardization committee ot the international society on thrombosis and haemostasis. Thromb Haemost 1993; 70: 361-369
• 11 Gandrille S, Goossens M, Aiach M. A scanning method to establish the molecular basis of protein C deficiencies. Hum Mut 1994; 4: 20-30
• 12 Gandrille S, Borgel D, Eschwege-Gufflet V, Aillaud MF, Dreyfus M, Matheron C, Gaussem P, Abgrall JF, Jude B, Sie P, Toulon P, Aiach M. Identification of 15 different candidate causal point mutations and 3 polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 1995; 85: 130-138
• 13 Gandrille S, Aiach M. the French INSERM netwoik on molecular abnormalities responsible for protein C and protein S deficiencies Identification of mutations in 90 out of 121 consecutive French patients with a type I protein C deficiency: A description of 35 novel mutations and 14 novel polymorphisms. Blood. 1994 (submitted)
• 14 Olds RJ, Lane DA, Chowdhury V, De Stefano V, Leone G, Thein SL. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. Biochemistry 1993; 32: 4216-4224
• 15 Olds RJ, Lane DA, Boisclair M, Sas G, Bock SC, Thein SL. Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F. Fed Eur Biochem Soc 1992; 300: 241-246
• 16 Chowdhury V, Lane DA, Mille B, Auberger K, Gandenberger-Bachem S, Pabinger I, Olds RJ, Thein SL. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis. Thromb Haemost 1994; 72: 198-202
• 17 Lane DA, Olds RJ, Conard J, Boisclair M, Bock SC, Hultin M, Abildgaard U, Ireland H, Thompson E, Sas G, Horellou MH, Tamponi G, Thein SL. Pleiotropic effects of antithrombin strand 1C substitution mutations. J Clin Invest 1992; 90: 2422-2433
• 18 Bock SC. Antithrombin III genetics, structure and function. In: Recombinant Technology in Hemostasis and Thrombosis,. edited by Hoyer LW, Drohan WN. New York, NY: Plenum Publishing Co; 1991: 25-45
• 19 Blajchman MA, Austin RC, Femandez-Rachubinski F, Sheffield WP. Molecular basis of inherited human antithrombin deficiency. Blood 1992; 80: 2159-2171
• 20 Schreuder HA, de Boer B, Dijkema R, Mulders J, Theunissen HJ M, Grootenhuis PDJ, Hol WG J. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Struct Biol 1994; 1: 48-54
• 21 Carrell RW, Stein PE, Fermi G, Wardell MR. Biological implications of a 3 A structure of dimeric antithrombin. Structure 1994; 2: 257-270
• 22 Devraj-Kizuk R, Chui DHK, Prochownik EV, Carter CJ, Ofosu FA, Blajchman MA. Antithrombin-III-Hamilton: A gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity. Blood 1988; 72: 1518-1523
• 23 Caso R, Lane DA, Thompson EA, Olds RJ, Thein SL, Panico M, Blench I, Morris HR, Freyssinet JM, Aiach M, Rodeghiero F. Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate. Br J Haematol 1991; 77: 87-92
• 24 Blajchman MA, Femandez-Rachubinski F, Sheffield WP, Austin RC, Schulman S. Antithrombin-III-Stockholm: A codon 392 (Gly to Asp) mutation with normal heparin binding and impaired serine protease reactivity. Blood 1992; 79: 1428-1434
• 25 Erdjument H, Lane DA, Panico M, Di Marzo V, Morris HR. Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow. J Biol Chem 1988; 263: 5589
• 26 Stephens AW, Thalley BS, Hirs CHW. Antithrombin-III Denver, a reactive site variant. J Biol Chem 1987; 262: 1044-1048
• 27 Brennan SO, Borg JY, George PM, Soria C, Soria J, Caen J, Carrell RW. New carbohydrate site in mutant antithrombin (7 lie to Asn) with decreased heparin affinity. Fed Eur Biochem Soc 1988; 237: 118-122
• 28 Borg JY, Brennan SO, Carrell RW, George P, Perry DJ, Shaw J. Antithrombin Rouen-IV 24 Arg to Cys. The amino-terminal contribution to heparin binding. Fed Eur Biochem Soc 1990; 266: 163-166
• 29 Chang JY, Tran TH. Antithrombin III Basel: Identification of a pro-leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity. J Biol Chem 1986; 261: 1174-1176
• 30 Koide T, Odani S, Takahashi K, Ono T, Salmagawa N. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin binding ability. Proc Natl Acad Sci USA 1984; 81: 289-293
• 31 Gandrille S, Aiach M, Lane DA, Vidaud D, Molho-Sabatier P, Caso R, de Moerloose P, Fiessinger JN, Clauser E. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine. J Biol Chem 1990; 265: 18997-19001
• 32 Okajima K, Abe H, Maeda S, Motomura M, Tsujihata M, Nagataki S, Okabe H, Takatsuki K. Antithrombin III Nagasaki (Seri 16-Pro): A heterozygous variant with defective heparin binding associated with thrombosis. Blood 1993; 81: 1300-1305
• 33 Mille B, Watton J, Barrowcliffe TW, Mani JC, Lane DA. Role of N- and C- terminal amino acids in antithrombin binding to pentasaccharide. J Biol Chem 1994; 269: 29435-29443
• 34 Brace D, Perry DJ, Borg JY, Carrell RW, Wardell MR. Thromboembolic disease due tothermolabile conformational changes of antithrombin Rouen- IV (187 Asn to Asp). J Clin Invest 1994; 94: 2265-2274
• 35 Gandrille S, Vidaud D, Emmerich J, Clauser E, Sie P, Fiessinger JN, Alhenc-Gelas M, Priollet P, Aiach M. Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon Ilia and a frameshift in exon VI. Br J Haematol 1991; 78: 414-420
• 36 Vidaud D, Emmerich J, Sirieix ME, Sie P, Alhenc-Gelas M, Aiach M. Molecularbasis for antithrombin III type I deficiency: Three novel mutations located in exon IV. Blood 1991; 78: 2305-2309
• 37 Emmerich J, Chadeuf G, Alhenc-Gelas M, Gouault-Heilmann M, Toulon P, Fiessinger JN, Aiach M. Molecularbasis of antithrombin type I deficiency: the first large in-frame deletion and two novel mutations in exon 6. Thromb Haemost 1994; 72: 534-539
• 38 Crystal RG. The a 1-antitrypsin gene and its deficiency states. Trends in Genetic 1989; 4: 411
• 39 Brodbeck RM, Brown JL. Study of the roles of proline 391 and a highly conserved sequence in the carboxyl-terminal region of members of the serpin family in the secretion of a 1-proteinase inhibitor. J Biol Chem 1994; 269: 17252-17256
• 40 Grundy CB, Thomas F, Millar DS, Krawczak M, Melissari E, Lindo V, Moffat E, Kakkar VV, Cooper DN. Recurrent deletion in the human antithrombin III gene. Blood 1991; 78: 1027-1032
• 41 Emmerich J, Vidaud D, Alhenc-Gelas M, Chadeuf G, Gouault-Heilmann M, Aillaud MF, Aiach M. Three novel mutations of antithrombin inducing high-molecular-mass compounds. ArteriosclerThromb 1994; 14: 1958-1965
• 42 Jochmans C, Lissens W, Yin T, Michiels JJ, van der Luit L, Peerlinck K, DeWaele M, Liebaers I. Molecularbasis fortype 1 antithrombin deficiency: Identification of two novel point mutations and evidence for a de novo splice site mutation. Blood 1994; 84: 3742-3748
• 43 Patracchini P, Aiello V, Palazzi P, Calzolari E, Bemardi F. Sublocalization of the human protein C gene on chromosome 2ql3-ql4. Hum Genet 1989; 81: 191-192
• 44 Plutzky J, Hoskins JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 1986 83: 546-550
• 45 Foster DC, Yoshitake S, Davi EE W. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-4677
• 46 Cheung A, Engelke JA, Sanders C, Suttie JW. Vitamin K-dependent carboxylase: Influence of the “propeptide” region on enzyme activity. Arch Biochan Biophys 1989; 274: 574-581
• 47 Bovill EG, Bauer KA, Dickerman JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73: 712-717
• 48 Allaart CF, Poort SR. Rosendaal FR. Reitsma PH. Bertina RM. Briet E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-138
• 49 Conard J, Horellou MH, Van Dreden P, Samama M, Reitsma PH, Poort S, Bertina RM. Homozygous protein C deficiency with late onset and recurrent coumarin-induced skin necrosis. Lancet 1992; 339: 743-742
• 50 Gandrille S, Jude B, Alhenc-Gelas M, Aiach M. Compound heterozygosity in a family with quantitative protein C deficiency illustrating the complexity of underlaying molecular mechanism. Thromb Haemost 1993; 70: 747-752
• 51 Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-562
• 52 Marlar RA, Montgomery RR, Broekmans AW. the Working Party Diagnosis and treatment of homozygous protein C deficiency. J Pediat 1989; 114: 528-534
• 53 Bovill EG, Tomczak JA, Grant B, Bhushan F, Pillemer E, Rainville IR, Long GL. Protein C_ymmt: Symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood 1992; 79: 1456-1465
• 54 Gandrille S, Alhenc-Gelas M, Gaussem P, Aillaud MF, Dupuy E, Juhan-Vague I, Aiach M. Five novel mutations located in exons III and IX of the protein C gene in patients with defective protein C anticoagulant activity. Blood 1993; 82: 159-168
• 55 Ido M, Ohiwa M, Hayashi T, Nishioka J, Hatada T, Watanabe Y, Wada H, Shirakawa S, Suzuki K. A compound heterozygous protein C deficiency with a single nucleotide G deletion encoding Gly-381 and an amino acid substitution of Lys for Gla-26. Thromb Haemost 1993; 70: 636-641
• 56 Poort SR, Pabinger-Fasching I, Mannhalter C, Reitsma PH, Bertina RM. Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency. Blood Coag Fibrinol 1993; 4: 273-280
• 57 Marchetti G, Patracchini P, Gemmati D, Castaman G, Rodeghiero F, Wacey A, Cooper DN, Tuddenham EGD, Bemardi F. Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381 JE Ser) in the substrate-binding pocket. Br J Haematol 1993; 84: 285-289
• 58 Gaussem P, Gandrille S, Duchemin J, Emmerich J, Alhenc-Gelas M, Aillaud MF, Aiach M. Influence of six mutations of the protein C gene of the Gla domain conformation and calcium affinity. Thromb Haemost 1994; 71: 748-754
• 59 Doig RG, Begley CG, McGrath KM. Hereditary protein C deficiency associated with mutations in exon IX of the protein C gene. Thromb Haemost 1994; 72: 203-208
• 60 Miyata T, Zheng YZ, Sakata T, Tsushima N, Kato H. Three missense mutations in the protein C heavy chain causing type I and type II protein C deficiency. Thromb Haemost 1994; 71: 32-37
• 61 Millar DS, Grundy CB, Bignell P, Moffat EH, Martin R, Kakkar VV, Cooper DN. A Gla domain mutation (Arg 15 to Trp) in the protein C (PROC) gene causing type 2 protein C deficiency and recurrent venous thrombosis. Blood Coag Fibrinol 1993; 4: 345-347
• 62 Zheng YZ, Sakata T, Matsusue T, Umeyama H, Kato H, Miyata T. Six missense mutations associated with type I and type II protein C deficiency and implications obtained from molecular modelling. Blood Coag Fibrinol 1994; 5: 687-696
• 63 Lu D, Bovill EG, Long GL. Molecular mechanism for familial protein C deficiency and thrombosis in protein C_Vertn{>nt(Glu 20 to Ala and Val 34 to Met). J Biol Chem 1994; 269: 29032-29038
• 64 Lu D, Kalafatis M, Mann KG, Long GL. Loss of membrane-dependant factor Va cleavage: A mechanistic interpretation of the pathology of protein C Vermont. Blood 1994; 84: 687-690
• 65 Rezaie A, Mather T, Sussman F, Esmon CT. Mutation of Glu-80 to Lys results in a protein C mutant that no longer requires Ca²⁺for rapid activation by the thrombin-thrombomodulin complex. J Biol Chem 1994; 269: 3151-3154
• 66 Fisher CL, Greengard JS, Griffin JH. Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen. Protein Sci 1994; 3: 588-599
• 67 Greengard JS, Fisher CL, Villoutreix B, Griffin JH. Structural basis fortype I and type II deficiencies of antithrombotic plasma protein C: Patterns revealed by three-dimensional molecular modelling of mutation of the protease domain. Proteins: Structure, Function, and Genetics. 1994; 18: 367-380
• 68 Matsuda M, Sugo T, Sakata Y, Murayama H, Mimuro J, Tanabe S, Yoshitake S. A thrombotic state due to an abnormal protein C. N Engl J Med 1988; 319: 1265-1268
• 69 Ohwada A, Takahashi H, Uchida K, Nukiwa T, Kira S. Gene analysis of heterozygous protein C deficiency in a patient with pulmonary arterial thromboembolism. Am Rev Respir Dis 1992; 145: 1491-1494
• 70 Grundy C, Chitolie A, Talbot S, Bevan D, Kakkar VV, Cooper DN. Protein C London I: recurrent mutation at Arg 169 (CGG to TGG) in the protein C gene causing thrombosis. Nucl Acid Res 1989; 17: 10513-10513
• 71 Tsay W, Greengard JS, Montgomery RR, McPherson RA, Fucci JC, Koerper MA, Coughlin J, Griffin JH. Genetic mutations in ten unreleted American patients with symptomatic type I protein C deficiency. Blood Coag Fibrinol 1993; 4: 791-796
• 72 Alhenc-Gelas M, Emmerich J, Gandrille S, Aubry ML, Fiessinger JN, Aiach M. Protein C perfusion in a patient with inherited protein C deficiency caused by two missense mutations: Arg 178 to Gin and Arg -1 to His. Blood Coag Fibrinol. 1994 (in press)
• 73 Reitsma PH, Poort SR, Allaart CF, Briet E, Bertina RM. The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects. Blood 1991; 78: 890-894
• 74 Romeo G, Hassan HJ, Staempfli S, Roncuzzi L, Cianetti L, Leonardi A, Vicente V, Mannucci PM, Bertina R, Peschle C, Cortese R. Hereditary thrombophilia: Identification of nonsense and missense mutations in the protein C gene. Proc Natl Acad Sci USA 1987; 84: 2829-32
• 75 Grundy C, Plendl H, Grote W, Zoll B, Kakkar VV, Cooper DN. A single base-pair deletion in the protein C gene causing recurrent thromboembolism. Thromb Res 1991; 61: 335-340
• 76 Grundy CB, Schulman S, Tengbom L, Kakkar VV, Cooper DN. Two novel missense mutations at Arg 178 of the protein C (PROC) gene causing recurrent venous thrombosis. Hum Genet 1992; 89: 685-686
• 77 Gandrille S, Vidaud M, Aiach M, Alhenc-Gelas M, Fischer AM, Gouault- Heilmann M, Toulon P, Fiessinger JN, Goossens M. Two novel mutations responsible for hereditary type I protein C deficiency. Characterization by denaturing gradient gel electrophoresis. Hum Mut 1992; 1 (06) 491-500
• 78 Soria JM, Fontcuberta J, Borrell M, Estivill X, Sala N. Protein C deficiency: Identification of a novel two-base pair insertion and two point mutations in exon 7 of the protein C gene in Spanish families. Hum Mut 1992; 1: 428-31
• 79 Yamamoto K, Tanimoto M, Emi N, Matsushita T, Takamatsu J, Saito H. Impaired secretion of the elongated mutant of protein C (protein C- Nagoya). Molecular and cellular basis for hereditary protein C deficiency J Clin Invest 1992; 90: 2439-2446
• 80 Millar DS, Wacey AI, Voke J, Kakkar VV, Cooper DN. A novel point mutation (Val 297 to Met) in the serine proteinase domain of protein C in a patient with both venous and arterial thromboembolic disease. Blood Coag Fibrinol 1993; 4: 631-633
• 81 Lind B, van Solinge WW, Schwartz M, Thorsen S. Splice site mutation in the human protein C gene associated with venous thrombosis: demonstration of exon skipping by ectopic transcript analysis. Blood 1993 82: 2423-2432
• 82 Millar DS, Grundy CB, Bignell P, Mitchell DC, Corden D, Woods P, Kakkar VV, Cooper DN. A novel nonsense mutation in the protein C (PROC) gene (Trp-29 M term) causing recurrent venous thrombosis. Hum Genet 1993; 91: 196
• 83 Soria JM, Fontcuberta J, Chillon M, Borrell M, Estivill X, Sala N. Acceptor splice site mutation in the invariant AG of intron 5 of the protein C gene, causing type I protein C deficiency. Hum Genet 1993; 92: 506-508
• 84 Tomczak JA, Ando RA, Sobel HG, Bovill EG, Long GL. Genetic analysis of a large kindred exhibiting type I protein C deficiency and associated thrombosis. Thromb Res 1994; 74: 243-254
• 85 Gandrille S, Jude B, Alhenc-Gelas M, Emmerich J, Aiach M. First de novo mutations in the protein C gene of two patients with type I deficiency: a missense mutation and a splice site deletion. Blood 1994; 84: 2566-2570
• 86 Grundy CB, Schulman S, Krawczak M, Kobosko J, Kakkar VV, Cooper DN. Protein C deficiency and thromboembolism: recurrent mutation at Arg 306 in the protein C gene. Hum Genet 1992; 88: 586-588
• 87 Millar DS, Allgrove J, Rodeck C, Kakkar VV, Cooper DN. A homozygous deletion/insertion mutation in the protein C (PROC) gene causing neonatal purpura fulminans: prenatal diagnosis in an at-risk pregnancy. Thromb Haemost 1994; 5: 647-649
• 88 Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planche C, Dehan M, Tchemia G. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325: 1565-1568
• 89 Long GL, Tomczak JA, Rainville IR, Dreyfus M, Schramm W, Schwarz HP. Homozygous type I protein C deficiency in two unrelated families exhibiting thrombophilia related to Ala 136 JE Pro of Arg 286/Emutations. Thromb Haemost 1994; 72: 526-533
• 90 Soria JM, Brito D, Barcelo J, Fontcuberta J, Botero L, Maldonado J, Estivill X, Sala N. Severe homozygous protein C deficiency: identification of a splice site missense mutation (184, Q M H) in exon 7 of the protein C gene. Thromb Haemost 1994; 72: 65-69
• 91 Grundy CB, Chisholm M, Kakkar VV, Cooper DN. A novel homozygous missense mutation in the protein C (PROC) gene causing recurrent venous thrombosis. Hum Genet 1992; 89: 683-684
• 92 Grundy CB, Lindo V, Kakkar VV, Melissari E, Scully MF, Cooper DN. Late-onset homozygous protein C deficiency. Lancet 1991; 338: 575-576
• 93 Melissari E, Kakkar VV. Congenital severe protein C deficiency in adults. Br J Haematol 1989; 72: 222-228
• 94 Yamamoto K, Matsushita T, Sugiura I, Takamatsu J, Iwasaki E, Wada H, Deguchi K, Shirakawa S, Saito H. Homozygous protein C deficiency: identification of a novel missense mutation that causes impaired secretion of the mutant protein C. J Lab Clin Med 1992; 119: 682-689
• 95 Witt I, Beck S, Seydewitz HH, Tasangil C, Schenck W. A novel homozygous missense mutation (Val 325 to Ala) in the protein C gene causing neonatal purpura fulminans. Blood Coag Fibrinol 1994; 5: 651-653
• 96 Sugahara Y, Miura O, Hirosawa S, Aoki N. Compound heterozygous protein C deficiency caused by two mutations, Arg-178 to Gin and Cys-331 to Arg, leading to impaired secretion of mutant protein C. Thromb Haemost 1994; 72: 814-818
• 97 Sugahara Y, Miura O, Yuen P, Aoki N. Protein C deficiency Hong Kong 1 and 2 Hereditary protein C deficiency caused by two mutant alleles, a 5- nucleotide deletion and a missense mutation. Blood 1992; 80: 126-133
• 98 Reitsma PH, Poort SR, Bemardi F, Gandrille S, Long GL, Sala N, Cooper DN. Protein C deficiency: A database of mutations. For the protein C and S subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thromb Haemost 1993; 69: 77-84
• 99 Reitsma PH, Bemardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN. Protein C deficiency: A database of mutations, 1995 update. Thromb Haemost. 1995 (submitted)
• 100 Miletich JP, Sherman L, Broze GJ. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-996
• 101 Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993; 72: 477-480
• 102 Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional riwk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-1035
• 103 Gandrille S, Greengard J, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M. the French network on the behalf of INSERM “Molecular abnormalities responsible for protein C and protein S deficiencies Incidence of activated protein C resistance due to the Arg 506 Gin mutation in factor V in 113 unrelated symptomatic protein C deficient patients. Blood. 1995 (accepted with modifications)
• 104 Watkins P, Eddy R, Fukushima Y, Byers M, Cohen E, Dackowski W, Wydro R, Shows T. The gene for protein S maps near the centomer of human chromosome 3. Blood 1988; 71: 238-241
• 105 Edenbrandt CM, Lund wall A, Wydro R, Stenflo J. Molecular analysis of the gene for vitamin K dependent protein S and its pseudogene. Cloning and partial gene organization. Biochemistry 1990; 29: 7861-7868
• 106 Ploos van Amstel HK, Reitsma PH, van der Logt PE, Bertina RM. Intron-exon organization of the active human protein S gene PSa and its pseudogene PSb: duplication and silencing during primate evolution. Biochemistry 1990; 29: 7853-7861
• 107 Schmidel DK, Tatro AV, Tomczak JA, Long GL. Organization of the human protein S genes. Biochemistry 1990; 29: 7845-7852
• 108 Dahlback B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement C4b-binding protein. Proc Natl Acad Sci USA 1981; 78: 2512-2516
• 109 Amiral J, Grosley B, Boyer-Neumann C, Marfaing-Koka A, Peynaud- Debayle E, Wolf M, Meyer D. New direct assay of free protein S antigen using two distinct monoclonal antibodies specific for the free form. Blood Coag Fibrinol 1994; 5: 179-186
• 110 Comp PC. Laboratory evaluation of protein S status. Semin Thromb Hemost 1990; 16: 177-181
• 111 Comp P, Esmon C. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984; 311: 1525-1528
• 112 Schwartz H, Fischer M, Hopmeier P, Batard MA, Griffin HH. Familial protein S deficiency is associated with recurrent thrombosis. Blood 1984; 64: 1297-1300
• 113 Girolami A, Simioni P, Lazzaro AR, Cordiano I. Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Thromb Haemost 1989; 61: 144-147
• 114 Allaart C, Aronson D, Ruys TH, Rosendaal F, Bockel J, Bertina RM, Briet E. Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost 1990; 64: 206-210
• 115 Schmidel DK, Nelson RM, Broxson Jr EH, Comp PC, Marlar RA, Long GL. A 5.3-kb deletion including exon XIII of the protein S a gene occurs in two protein S-deficient families . Blood 1991; 77: 551-559
• 116 Ploos van Amstel HK, Huisman MV, Reitsma PH, ten Cate JW, Bertina RM. Partial protein S gene deletion in a family with hereditary thrombophilia. Blood 1989; 73: 479-483
• 117 Reitsma PH, Ploos van Amstel HK, Bertina RM. Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I. J Clin Invest 1994; 93: 486-492
• 118 Borgel D, Gandrille S, Gouault-Heilmarin M, Aiach M. First frameshift mutation in the active protein S gene associated with a quantitative hereditary deficiency. Blood Coag Fibrinol 1994; 5: 593-600
• 119 Gomez E, Ledford MR, Pegelow CH, Reitsma PH, Bertina RM. Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost 1994; 71: 723-726
• 120 Hayashi T, Nishidka J, Shigekiyo T, Saito S, Suzuki K. ProteinSTokushima: Abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domains of protein S. Blood 1994; 83: 683-690